HAL (France)
open access
GDF5 modulation of MuSC pool as a potential therapeutic benefit for DMD
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Aptamer-Based Delivery Systems for VEGF and NGF Modulation in Ocular Therapies.#297352
- High-dose Furmonertinib for First-line Treatment of EGFR Mutated NSCLC With Central Nervous System (CNS) Metastases#1030249
- Transgenic mouse models for investigating human DUX4 expression during development and its roles in FSHD pathophysiology#1250466
- Increased sensitivity to myopia and altered retinal ON/OFF balance in a mouse model lacking Dusp4#1311839
- Efficacy and Safety of Disitamab Vedotin Plus Pyrotinib or Naratinib in HER2-positive Breast Cancer Patients With Brain Metastasis#1370904
Record · ID 1235763
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive